Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria. Expert opinion on pharmacotherapy. 2016.R. G. D'angelo, J. K. Johnson, J. T. Bork, and E. L. Heil, "Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria," ...
Objective To analyze occurrence of Gram-negative bacteria producing extended-spectrum 尾-lactamase (ESBL) in patients with lower respiratory tract infectio... J Long - 《Journal of First Military Medical University》 被引量: 23发表: 2004年 Detection of AmpC β-lactamase and drug resistance of En...
Detection of extended spectrum beta lactamases (ESBL), Amp C and carbapenemases would help implementing empirical treatment in bacteremia patients. There is a need of a simple and inexpensive screening test for multidrug resistant isolates. A total of 125 multidrug resistant isolates of ...
AmpCenzymebacteriaresistancetoceftriaxone,aztreonam,cefotaximeand cefotaximehavesignicantlylowerthanthatofenzymeproducingbacteria,the differencewasstatisticallysignicant(P<0.05).ConclusionESBLsandAmpC enzymeistheimportantcauseofbacteriaresistance,canbeinaccordancewith theactualdrugsusceptibilityresultstakereasonabletreatment....
Indeed, ESBL-producing bacteria have been isolated on lettuce in Burkina Faso [35]. The common intestinal carriage of these bacteria may increase their prevalence in patients visiting healthcare centers, where the presence of these bacteria leads to complications of therapeutic treatment, prolonged ...
结论 产AmpC酶黏质沙雷菌对临床常用抗菌药物的耐药率均较高,对产酶株临 床经验用药可选用碳青霉烯类、氟喹喏酮类及四代头孢菌素类抗菌药物。 [关键词] 粘质沙雷菌;AmpC酶;抗菌药物;细菌耐药性 doi:10.3969/i.issn.1000—0399.2012.02.001 AntimicrobialresistanceofAmpC—producingserratiamarcescensinAnhui yn Half...
Muller, C.K. Naber, P. Nihoyannopoulos, A. Moritz, J.L. Zamorano, ESC Committee for Practice Guidelines Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the prevention, diagnosis, and treatment of infective endocarditis of ...
response to glucagon (Figs 2fand4b); (3) AMPK phosphorylated purified PDE4Bin vitro(Fig. 5a–c), resulting in an increase inVmax(Fig. 5d), and mutation of Ser304 to Ala abolished phosphorylation-induced PDE activation by AMPK (Fig. 5e); and (4) 991 treatment led to increased PDE4B ...
p99.ConclusionTheincidenceofAmpC-producingstrainwasratherhish.MostoftheAmpC-producingstrainsWCl'℃multidrugresistance,andimipenemisstilltheproperantibioticfortreatmentoftheinfectionscausedbyAmpC-producingbacteria.AmpCenzymewasoneofthecauseofEnte*obactercloacae’resistance,ThemutantofampCstructuregenemaybeassociated...
During antibiotic treatment, the balance of peptidoglycan synthesis is compromised, releasing GlcNAc-anhydro-MurNAc-oligopeptides into the periplasm. Resulting murapeptides are transported into the cytosol by an AmpG transporter encoded by ampG [25]. However, AmpG has no influence on ampC induction...